drugset / Trial / NCT00619866
An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to see how elagolix works compared to placebo in women with endometriosis and to see the effect, if any, on bone mineral density.
Timeline
- Start
- 2008-02-19
- Primary completion
- 2009-04-20
- Completion
- 2009-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elagolix | Small molecule | 150 mg | Oral |
| Subject | Elagolix | Small molecule | 250 mg | Oral |